{"id":"https://openalex.org/W2027437226","doi":"https://doi.org/10.1158/1538-7445.am10-4492","title":"Abstract 4492: BEZ235, a dual PI3K/mTOR inhibitor, enhances the activity of the multikinase inhibitor sorafenib in acute myeloid leukemia (AML)","display_name":"Abstract 4492: BEZ235, a dual PI3K/mTOR inhibitor, enhances the activity of the multikinase inhibitor sorafenib in acute myeloid leukemia (AML)","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W2027437226","doi":"https://doi.org/10.1158/1538-7445.am10-4492","mag":"2027437226"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am10-4492","doi":"https://doi.org/10.1158/1538-7445.am10-4492","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-4492","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036019071","display_name":"Akira Shimada","orcid":"https://orcid.org/0000-0001-5207-3779","observed_orcids":["https://orcid.org/0000-0001-5207-3779"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Akira Shimada","raw_affiliation_strings":["1St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036072430","display_name":"Brian D. Furmanski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Furmanski","raw_affiliation_strings":["1St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102768881","display_name":"Hongmei Niu","orcid":"https://orcid.org/0000-0001-8660-2544","observed_orcids":["https://orcid.org/0000-0001-8660-2544"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hongmei Niu","raw_affiliation_strings":["1St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077955893","display_name":"Shuiying Hu","orcid":"https://orcid.org/0000-0002-9806-7734","observed_orcids":["https://orcid.org/0000-0002-9806-7734"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuiying Hu","raw_affiliation_strings":["1St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075936752","display_name":"Hiroto Inaba","orcid":"https://orcid.org/0000-0003-0605-7342","observed_orcids":["https://orcid.org/0000-0003-0605-7342"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hiroto Inaba","raw_affiliation_strings":["1St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharyn D. Baker","raw_affiliation_strings":["1St. Jude Children's Research Hospital, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1St. Jude Children's Research Hospital, Memphis, TN","institution_ids":["https://openalex.org/I1313298211"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1313298211"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"8_Supplement","first_page":"4492","last_page":"4492"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.7548999786376953,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.7548999786376953,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.23999999463558197,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bez235","display_name":"BEZ235","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pi3k-mtor-inhibitors","display_name":"PI3K/mTOR inhibitors","score":0.8100000023841858},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pediatric-acute-myeloid-leukemia","display_name":"pediatric acute myeloid leukemia","score":0.8370000123977661},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7850000262260437},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8650000095367432},{"id":"https://openalex.org/keywords/ras-mapk-pathway","display_name":"RAS/MAPK pathway","score":0.9229999780654907},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.7289999723434448},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8700000047683716},{"id":"https://openalex.org/keywords/phospho-akt","display_name":"phospho-Akt","score":0.550000011920929},{"id":"https://openalex.org/keywords/phospho-erk","display_name":"phospho-ERK","score":0.7900000214576721},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.3479999899864197},{"id":"https://openalex.org/keywords/aml-cell-lines","display_name":"AML cell lines","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7703741788864136},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.7042727470397949},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5989201068878174},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.5805988907814026},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.524850606918335},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5226100087165833},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.43505704402923584},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.401969313621521},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3785043954849243},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3587290048599243},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33265435695648193},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.12598729133605957},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am10-4492","doi":"https://doi.org/10.1158/1538-7445.am10-4492","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-4492","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2140737563","https://openalex.org/W2562206761","https://openalex.org/W1701902327","https://openalex.org/W2531031953","https://openalex.org/W2531893907","https://openalex.org/W216104070","https://openalex.org/W3089964895","https://openalex.org/W2566856818","https://openalex.org/W2230395776","https://openalex.org/W2558830983"],"abstract_inverted_index":{"Abstract":[0],"The":[1,25],"PI3K/Akt/mTOR":[2],"and":[3,61,128,142,155,157,168,245,248,258,285,306,317,410],"RAS/RAF/MEK/ERK":[4],"signaling":[5,53,106],"pathways":[6],"are":[7,33,415],"activated":[8],"in":[9,35,54,88,98,129,134,147,184,187,201,233,243,256,263,279,313,324,341,365,374,404,406,422],"50":[10,362],"to":[11,50,192,208,224,239,274,347,354,361,363,387,417],"75%":[12],"of":[13,59,63,69,93,104,118,182,195,219,250,276,301,304,402,426,436,441],"primary":[14,38,159,318,376,411],"AML":[15,40,99,149,161,185,314,333,378,407],"cases,":[16],"which":[17],"have":[18,80],"been":[19],"associated":[20],"with":[21,101,131,165,170,288,327,382],"poor":[22],"long-term":[23],"outcome.":[24],"class":[26],"I":[27],"PI3K":[28],"isoforms":[29],"\u03b1,":[30],"\u03b2,":[31],"\u03b4":[32],"expressed":[34],"nearly":[36],"all":[37,366,375],"childhood":[39,160,377],"blast":[41,162,319,412],"samples":[42,163,320,380],"(Ross,":[43],"Blood":[44],"2004),":[45],"providing":[46],"a":[47,85,125,202,423],"potential":[48],"target":[49],"circumvent":[51],"aberrant":[52],"this":[55],"pathway.":[56],"However,":[57],"because":[58],"cross-talk":[60],"redundancy":[62],"signal":[64],"transduction":[65],"pathways,":[66],"rational":[67],"combinations":[68],"inhibitors":[70],"may":[71],"represent":[72],"an":[73,231],"advantageous":[74],"treatment":[75,92],"strategy":[76],"for":[77,90,197,228,292,310,445],"AML.":[78,427],"We":[79,176,295],"previously":[81],"shown":[82],"that":[83,321],"sorafenib,":[84],"multikinase":[86],"inhibitor":[87,122],"development":[89],"the":[91,115,119,179,298,302,357,383,400,419,437,442],"AML,":[94],"effectively":[95],"inhibits":[96],"phosho-ERK":[97],"cells,":[100,247],"limited":[102,395],"inhibition":[103,214,249],"AKT":[105],"(Hu,":[107],"Mol":[108],"Cancer":[109,446,456],"Ther,":[110],"2008).":[111],"Here":[112],"we":[113],"evaluated":[114,178],"anti-leukemic":[116,299],"activity":[117,181,300,397,401],"dual":[120],"PI3K/mTOR":[121],"BEZ235":[123,141,183,196,225,289,305,350,393],"as":[124,343],"single":[126,388],"agent":[127,389],"combination":[130,303,358,385,421],"sorafenib":[132,307,336,403],"at":[133],"vivo":[135],"relevant":[136],"concentrations":[137,194],"(\u2264":[138],"1":[139,226,290,293],"\u00b5M":[140,145,227,291,338,352],"\u2264":[143],"10":[144,337],"sorafenib)":[146],"four":[148],"cell":[150,264,281,315,334,367,408],"lines":[151,282,316,409],"(HL60,":[152],"U937,":[153],"THP-1,":[154,284],"OCI-AML3),":[156],"9":[158],"(7":[164],"wild-type":[166],"FLT3":[167,171],"2":[169],"internal":[172],"tandem":[173],"duplication":[174],"mutations).":[175],"first":[177],"single-agent":[180,396],"cells":[186,345],"suspension":[188],"culture.":[189],"After":[190,222],"exposure":[191,223,309],"increasing":[193],"72h,":[198],"IC50":[199],"values":[200],"MTT":[203],"assay":[204],"ranged":[205],"from":[206],"0.125":[207],"0.5":[209],"\u00b5M,":[210],"but":[211,398],"maximal":[212],"growth":[213],"did":[215],"not":[216],"exceed":[217],"40%":[218],"untreated":[220,277],"controls.":[221],"72":[229,311],"h,":[230],"increase":[232],"apoptosis":[234,340,360,370],"(Annexin":[235],"V":[236],"positive":[237],"cells)":[238],"30%":[240],"was":[241,254,267,270,371],"observed":[242,255,373],"U937":[244,257],"OCI-AML3":[246],"proliferation":[251],"(EdU":[252],"incorporation)":[253],"THP-1":[259],"cells;":[260],"no":[261],"change":[262],"cycle":[265],"distribution":[266],"observed.":[268],"Phospho-Akt":[269],"inhibited":[271],"by":[272],"50%":[273],"80%":[275],"controls":[278],"3":[280],"(U937,":[283],"HL-60)":[286],"treated":[287,381],"h.":[294],"next":[296],"examined":[297],"(simultaneous":[308],"h)":[312],"were":[322],"co-cultured":[323],"direct":[325],"contact":[326],"bone-marrow-derived":[328],"mesenchymal":[329],"stromal":[330],"cells.":[331],"In":[332,391],"lines,":[335],"induced":[339],"twice":[342],"many":[344],"(39%":[346],"54%)":[348],"than":[349],"1.0":[351],"(17%":[353],"23%);":[355],"however,":[356],"increased":[359],"68%":[364],"lines.":[368],"Enhanced":[369],"also":[372],"blasts":[379],"drug":[384,420],"compared":[386],"treatment.":[390],"conclusion,":[392],"has":[394],"enhances":[399],"vitro":[405],"samples.":[413],"Studies":[414],"ongoing":[416],"evaluate":[418],"xenograft":[424],"model":[425],"Citation":[428],"Format:":[429],"{Authors}.":[430],"{Abstract":[431],"title}":[432],"[abstract].":[433],"In:":[434],"Proceedings":[435],"101st":[438],"Annual":[439],"Meeting":[440],"American":[443],"Association":[444],"Research;":[447],"2010":[448],"Apr":[449],"17-21;":[450],"Washington,":[451],"DC.":[452],"Philadelphia":[453],"(PA):":[454],"AACR;":[455],"Res":[457],"2010;70(8":[458],"Suppl):Abstract":[459],"nr":[460],"4492.":[461]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2016-06-24T00:00:00"}